Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age.
Diamant ThaҫiShelly KafkaRaphael J DeHoratiusStephen XuElizabeth C HsiaAnthony TurkiewiczPublished in: Arthritis research & therapy (2019)
clinicaltrials.gov: NCT00973479 . Registered September 9, 2009.